22 mai 2023 Associé à Hugues de Thé, chaire Oncologie cellulaire et moléculaire Documents et médias Télécharger le programme pdf (380.33 Ko) Programme Colloque 22 mai 2023 09:15 - 09:30 Colloque Hugues de Thé Introduction Revisited Chemotherapy Colloque 22 mai 2023 09:30 - 10:00 Colloque Rene Bernards New Approaches to Cancer Therapy Revisited Chemotherapy Colloque 22 mai 2023 10:00 - 10:30 Colloque Yves Pommier Precision Oncology with DNA Targeted Agents and the NCI PatientMiner Web Application Revisited Chemotherapy Colloque 22 mai 2023 10:30 - 10:50 Colloque Sophie Postel-Vinay Harnessing Genetic Vulnerabilities in Immuno-Oncology: Novel Therapeutic Opportunities Revisited Chemotherapy Colloque 22 mai 2023 11:20 - 11:50 Colloque Thomas Helleday Killing Cancer by DNA Damage Through Synthetic Lethality Revisited Chemotherapy Colloque 22 mai 2023 14:00 - 14:30 Colloque Jean-Emmanuel Sarry Metabolic Bases of Responses to Chemotherapy in Leukemia Revisited Chemotherapy Colloque 22 mai 2023 14:30 - 15:00 Colloque Guillaume Bossis SUMOylation Controls Acute Myeloid Leukemias Response to (Chemo)therapies Revisited Chemotherapy Colloque Non enregistré 22 mai 2023 15:20 - 15:50 Colloque Non enregistré Filipe Cabreiro Microbially Derived Adjuvants for Cancer Chemotherapy Revisited Chemotherapy Colloque 22 mai 2023 15:50 - 16:20 Colloque Clemens Schmitt Revisiting Chemotherapy Failure—From a Senescence Point-of-view Revisited Chemotherapy Colloque 22 mai 2023 16:20 - 17:00 Colloque Hugues de Thé Conclusions Revisited Chemotherapy
Colloque 22 mai 2023 09:30 - 10:00 Colloque Rene Bernards New Approaches to Cancer Therapy Revisited Chemotherapy
Colloque 22 mai 2023 10:00 - 10:30 Colloque Yves Pommier Precision Oncology with DNA Targeted Agents and the NCI PatientMiner Web Application Revisited Chemotherapy
Colloque 22 mai 2023 10:30 - 10:50 Colloque Sophie Postel-Vinay Harnessing Genetic Vulnerabilities in Immuno-Oncology: Novel Therapeutic Opportunities Revisited Chemotherapy
Colloque 22 mai 2023 11:20 - 11:50 Colloque Thomas Helleday Killing Cancer by DNA Damage Through Synthetic Lethality Revisited Chemotherapy
Colloque 22 mai 2023 14:00 - 14:30 Colloque Jean-Emmanuel Sarry Metabolic Bases of Responses to Chemotherapy in Leukemia Revisited Chemotherapy
Colloque 22 mai 2023 14:30 - 15:00 Colloque Guillaume Bossis SUMOylation Controls Acute Myeloid Leukemias Response to (Chemo)therapies Revisited Chemotherapy
Colloque Non enregistré 22 mai 2023 15:20 - 15:50 Colloque Non enregistré Filipe Cabreiro Microbially Derived Adjuvants for Cancer Chemotherapy Revisited Chemotherapy
Colloque 22 mai 2023 15:50 - 16:20 Colloque Clemens Schmitt Revisiting Chemotherapy Failure—From a Senescence Point-of-view Revisited Chemotherapy
